A Phase Ia/Ib, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of RSC-1255 in Patients with Advanced Solid Tumor Malignancies

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

ESCALATION: tissue agnostic EXPANSION: panc, lung, colon w/ RAS mutation and glioblastoma (w or w/o mutations )

Type of Study

Treatment

Locations

University of Colorado Hospital

Principal Investigator
Wells Messersmith,  MD

Wells Messersmith, MD

Study ID

Protocol Number: 20-3038

More information available at ClinicalTrials.gov: NCT04678648

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers